Skip to search formSkip to main contentSkip to account menu

framon

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
[Glycoprotein IIb-IIIa antagonist Monafram in primary angioplasty of patients with acute coronary syndrome without st segment elevation].
Glycoprotein (GP) llb-llla anagonist monafram is the F(ab)2 fragments of anti GP llb llla monoclonal antibody FraMon (CRC64… 
2005
2005
[Results of clinical trials of a novel glycoprotein IIb-IIIa antagonist framon in high-risk coronary angioplasty].
New glycoprotein (GP) IIb-IIIa antagonist preparation framon (Monafram), is the F(ab')(2) fragment of a monoclonal antibody… 
2004
2004
PHARMACOKINETICS OF F(AB)2 FRAGMENT OF ANTI-GLICOPROTEIN IIb-IIIa MONOCLONAL ANTIBODY FRaMon IN HIGH-RISK CORONARY ANGIOPLASTY: P1.165
2003
2003
Role of Glycoprotein IIb-IIIa (αIIbβ3-integrin) in Stimulation of Secretion from Platelet Granules
The involvement of glycoprotein (GP) IIb-IIIa (αIIbβ3-integrin) in the stimulation of secretion from platelet dense and… 
2002
2002
[Pharmacodynamics, safety, and clinical effects of a novel glycoprotein IIb/IIIa antagonist framon during high risk coronary angioplasty].
Preparation framon [F(ab')2 fragments of the anti-glycoprotein (GP) IIb/IIIa monoclonal antibody (FRaMon)] blocks fibrinogen… 
2001
2001
[Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
AIM To study the effects of F(ab')2 fragments of the monoclonal antibody (monAB) FRaMon against glycoproteins (GP) IIb-IIIa on… 
2001
2001
Inhibition of platelet aggregation by F(ab′)2 fragments of monoclonal antibody framon (CRC64) against glycoproteins IIB-IIIA in vitro and in healthy volunteers